Trials / Completed
CompletedNCT04988919
Consumption of 4D Dietary Supplement on Perceptual-Cognitive and Visual-Motor Performance
Acute Consumption of 4D Dietary Supplement vs. Placebo: Effects on Perceptual-Cognitive and Visual-Motor Performance
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 24 (actual)
- Sponsor
- University of Central Florida · Academic / Other
- Sex
- All
- Age
- 18 Years – 40 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this investigation is to determine if supplementation with the 4D dietary supplement impacts perceptual-cognitive and visual-motor skills in healthy individuals.
Detailed description
Multi-ingredient supplements (MIS) have been reported to positively impact various aspects of performance. While caffeine alone has been shown to improve aerobic performance, resistance training (such as bench press), reaction time and sprint performance, it has also been suggested that it lacks the ability to improve cognition. Therefore, the purpose of this investigation is to examine the effects of a caffeine containing MIS on measures of cognition and reaction time, with the intent of providing additional benefits to athletic performance. This study will utilize a randomized, double-blind, placebo-controlled design. Following two familiarization trials, participants will complete two testing visits. During these visits, they will complete baseline assessments, consume either the 4D dietary supplement or a taste matched placebo, and rest for 45 minutes. Reaction time, cognition assessments (visual tracking speed), and reactive agility performance will be assessed following the rest period.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | 4D | multi-ingredient supplement mixed with 24 ounces of water |
| DIETARY_SUPPLEMENT | placebo | taste-matched placebo mixed with 24 ounces of water |
Timeline
- Start date
- 2021-07-26
- Primary completion
- 2021-10-04
- Completion
- 2021-10-04
- First posted
- 2021-08-04
- Last updated
- 2021-10-08
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT04988919. Inclusion in this directory is not an endorsement.